ICON plc (ICLR) Tops Q3 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
ICON Announces Executive Leadership Transition
October 20, 2016 4:15 AM EDTMr. Ciaran Murray to transition to Chairman, effective 1st March 2017 Dr. Steve Cutler to be appointed Chief Executive Officer, effective 1st March 2017
DUBLIN--(BUSINESS WIRE)-- ICON plc, (NASDAQ: ICLR) a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device... More
ICON Reports Third Quarter 2016 Results
October 20, 2016 4:00 AM EDTHighlights
Net business wins of $510 million; net book to bill of 1.21. Backlog of business grows 11.8% year on year to $4.25 billion. Net revenue increases 6.4% to $420 million in the quarter. Income from operations increases 13.7% to 19.3% of revenue before non-recurring charges. Earnings per share increases 17% to $1.19 before non-recurring charges.DUBLIN--(BUSINESS WIRE)--... More
